Status:
RECRUITING
Prospective Cohort Study of Intracerebral Hemorrhage
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Intracerebral Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis ...
Detailed Description
Intracerebral hemorrhage (ICH) remains a devastating disease with high mortality, yet few therapeutic managements have been proved effective. Large quantities of work needs to be done to fully delinea...
Eligibility Criteria
Inclusion
- Hospitalized patients over 18 years old of primary intracerebral hemorrhage.
Exclusion
- patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor.
- isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients；
- surgical evacuation of hematoma；
- unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI
- patients cannot be followed up for any reasons.
- patients death in 24 hours
- pregnant patients
Key Trial Info
Start Date :
December 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
856 Patients enrolled
Trial Details
Trial ID
NCT04707105
Start Date
December 29 2020
End Date
December 1 2026
Last Update
March 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Affiliated Hospital, School of Medicine at Zhejiang University
Hangzhou, Zhejiang, China, 310000